By Myles Starr
Active drug shortages in the United States are down from an all-time high of 323 in early 2024. However, a new ASHP report reveals that shortages remain stubbornly high, with 270 reported through the first quarter of 2025.
“Even though the number of shortages has remained fairly flat for the last three quarters, they are still a problem,” Michael Ganio, PharmD, BCPS, FASHP, the senior director of pharmacy practice and quality at ASHP, told Specialty Pharmacy Continuum.